Overexpressing of PP2Ac in mouse CD4+ T cells may partly results in SLE pathogenesis aimed at modulating IL-17 locus by increasing H3 acetylation via the activation of interferon regulatory factor 4. The gene discussed is IL17A; the disease is systemic lupus erythematosus.